Skip to main content
Top
Published in: BMC Cancer 1/2006

Open Access 01-12-2006 | Research article

The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women

Authors: Vandana A Govan, Debbie Constant, Margaret Hoffman, Anna-Lise Williamson

Published in: BMC Cancer | Issue 1/2006

Login to get access

Abstract

Background

Cervical cancer is due to infection with specific high-risk types of human papillomavirus (HPV). Although the incidence of genital HPV infection in various population groups is high, most of these regress without intervention. Investigating genetic host factors and cellular immune responses, particularly cytokines, could help to understand the association between genital HPV infection and carcinogenesis. The tumor necrosis factor alpha (TNF-α) cytokine plays an important role in all stages of cervical cancer and has the ability to induce the regression of human tumors. Therefore the aim of the study was to investigate the allelic distribution of -308 TNF-α gene polymorphism in South African women with cervical cancer compared to control women.

Methods

Included in our study were women with histologically proven cancer of the cervix (n = 244) and hospital-based controls (n = 228). All patients and controls were from mixed race and black population groups in South Africa. The detection of a bi-allelic -308 (A/G) polymorphism in the promoter region of TNF-α was investigated using the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) technique. The distributions of the allelic frequencies were stratified in both patients and controls into two South African ethnic population groups.

Results

In this study we observed no association between the distribution of -308 TNF-α polymorphism and the risk of developing cervical cancer even after combining the data from the two ethnic populations (X2 = 2.26). In addition, using the chi-squared test we found no significant association between the known risk factors for cervical cancer and the allele distribution of -308 TNF-α. However, the frequency of the rare high-producing allele -308A of TNF-α was significantly lower in the South African population when compared to Caucasians and Chinese population groups.

Conclusion

We demonstrated no association between -308 TNF-α polymorphism and the risk of cervical cancer among two South African ethnic population groups. However, as the distribution of the -308A TNF-α was notably different between the control groups of South Africa and other population groups this result suggests that ethnic disparity may influence the levels of TNF-α produced.
Literature
1.
go back to reference zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell host in early events in carcinogenesis. J Natl Cancer Inst. 2002, 92: 690-698. 10.1093/jnci/92.9.690.CrossRef zur Hausen H: Papillomaviruses causing cancer: evasion from host-cell host in early events in carcinogenesis. J Natl Cancer Inst. 2002, 92: 690-698. 10.1093/jnci/92.9.690.CrossRef
2.
go back to reference Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J: The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998, 132: 277-284. 10.1016/S0022-3476(98)70445-7.CrossRefPubMed Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, Palefsky J: The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998, 132: 277-284. 10.1016/S0022-3476(98)70445-7.CrossRefPubMed
3.
go back to reference Wu TC: Immunology of the human papillomavirus in relation to cancer. Curr Opin Immunol. 1994, 6: 746-754. 10.1016/0952-7915(94)90079-5.CrossRefPubMed Wu TC: Immunology of the human papillomavirus in relation to cancer. Curr Opin Immunol. 1994, 6: 746-754. 10.1016/0952-7915(94)90079-5.CrossRefPubMed
4.
go back to reference Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH: Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst. 1997, 89: 1285-1293. 10.1093/jnci/89.17.1285.CrossRefPubMed Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH: Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst. 1997, 89: 1285-1293. 10.1093/jnci/89.17.1285.CrossRefPubMed
5.
go back to reference Clerici M, Merola M, Ferrario E, Trabattoni D, Villa Ml, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E: Cytokine production patterns in cervical intraepithelial neoplasia: An association with human papillomavirus infection. J Natl Cancer Inst. 1997, 89: 245-250. 10.1093/jnci/89.3.245.CrossRefPubMed Clerici M, Merola M, Ferrario E, Trabattoni D, Villa Ml, Stefanon B, Venzon DJ, Shearer GM, De Palo G, Clerici E: Cytokine production patterns in cervical intraepithelial neoplasia: An association with human papillomavirus infection. J Natl Cancer Inst. 1997, 89: 245-250. 10.1093/jnci/89.3.245.CrossRefPubMed
6.
go back to reference Govan VA, Carrara HRO, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL: Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J of Carcinogenesis. 2003, 2: 3-10.1186/1477-3163-2-3.CrossRef Govan VA, Carrara HRO, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL: Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J of Carcinogenesis. 2003, 2: 3-10.1186/1477-3163-2-3.CrossRef
7.
go back to reference Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, Lin MT, Wang HP, Lin JT: Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis. 2002, 185: 106-109. 10.1086/324771.CrossRefPubMed Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, Lin MT, Wang HP, Lin JT: Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis. 2002, 185: 106-109. 10.1086/324771.CrossRefPubMed
8.
go back to reference Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: Genotype-phenotype association study in Japanese cases. Am J Med Genet. 2002, 114: 436-439. 10.1002/ajmg.10417.CrossRefPubMed Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: Genotype-phenotype association study in Japanese cases. Am J Med Genet. 2002, 114: 436-439. 10.1002/ajmg.10417.CrossRefPubMed
9.
go back to reference Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH: Host genetic polymorphism analysis in cervical cancer. Clin Chem. 2002, 48 (8): 1218-24.PubMed Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, Smith DI, Gostout BS, Persing DH: Host genetic polymorphism analysis in cervical cancer. Clin Chem. 2002, 48 (8): 1218-24.PubMed
10.
go back to reference Kroeger KM, Carville KS, Abraham LJ: The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997, 34 (5): 391-9. 10.1016/S0161-5890(97)00052-7.CrossRefPubMed Kroeger KM, Carville KS, Abraham LJ: The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol. 1997, 34 (5): 391-9. 10.1016/S0161-5890(97)00052-7.CrossRefPubMed
11.
go back to reference Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci. 1975, 72 (9): 3666-70.CrossRefPubMedPubMedCentral Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci. 1975, 72 (9): 3666-70.CrossRefPubMedPubMedCentral
12.
go back to reference Shishodia S, Majumdar S, Banerjee S, Aggarwal BB: Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosporylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 2003, 63: 4375-4383.PubMed Shishodia S, Majumdar S, Banerjee S, Aggarwal BB: Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosporylation: Correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 2003, 63: 4375-4383.PubMed
13.
go back to reference Raabe T, Bukrinsky M, Currie RA: Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem. 1998, 273 (2): 974-80. 10.1074/jbc.273.2.974.CrossRefPubMed Raabe T, Bukrinsky M, Currie RA: Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem. 1998, 273 (2): 974-80. 10.1074/jbc.273.2.974.CrossRefPubMed
14.
go back to reference Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH: The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001, 66 (1): 41-6. 10.1016/S0304-3835(01)00438-4.CrossRef Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, Kim HI, Kim MS, Paik KH: The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett. 2001, 66 (1): 41-6. 10.1016/S0304-3835(01)00438-4.CrossRef
15.
go back to reference Kirkpatrick A, Bidwell J, van den Brule AJ, Meijer CJ, Pawade J, Glew S: TNF alpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol. 2004, 92 (2): 675-9. 10.1016/j.ygyno.2003.11.025.CrossRefPubMed Kirkpatrick A, Bidwell J, van den Brule AJ, Meijer CJ, Pawade J, Glew S: TNF alpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol. 2004, 92 (2): 675-9. 10.1016/j.ygyno.2003.11.025.CrossRefPubMed
16.
go back to reference Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, Park JY, Kim JH, Yoo JY: Association of polymorphism of IL-10 and TNF-α genes with gastric cancer in Korea. Cancer Lett. 2005, 225 (2): 207-214. 10.1016/j.canlet.2004.11.028.CrossRefPubMed Lee JY, Kim HY, Kim KH, Kim SM, Jang MK, Park JY, Kim JH, Yoo JY: Association of polymorphism of IL-10 and TNF-α genes with gastric cancer in Korea. Cancer Lett. 2005, 225 (2): 207-214. 10.1016/j.canlet.2004.11.028.CrossRefPubMed
17.
go back to reference Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW: Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004, 6 (4): R395-400. 10.1186/bcr802.CrossRefPubMedPubMedCentral Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, Brown NJ, Reed MW: Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res. 2004, 6 (4): R395-400. 10.1186/bcr802.CrossRefPubMedPubMedCentral
18.
go back to reference Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM: TNF-a promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. JID. 2005, 191: 969-976. 10.1086/427826.CrossRefPubMed Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, Peyton CL, Wheeler CM: TNF-a promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. JID. 2005, 191: 969-976. 10.1086/427826.CrossRefPubMed
19.
go back to reference Tjiong MY, van der Vange N, ter Schegget JS, Burger MPM, ten Kate FWJ, Out TA: Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine. 2001, 14: 357-360. 10.1006/cyto.2001.0909.CrossRefPubMed Tjiong MY, van der Vange N, ter Schegget JS, Burger MPM, ten Kate FWJ, Out TA: Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine. 2001, 14: 357-360. 10.1006/cyto.2001.0909.CrossRefPubMed
20.
go back to reference Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH: Tumor necrosis factor alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol. 1996, 104: 154-159. 10.1046/j.1365-2249.1996.d01-647.x.CrossRefPubMedPubMedCentral Chen G, Wilson R, Wang SH, Zheng HZ, Walker JJ, McKillop JH: Tumor necrosis factor alpha (TNF-α) gene polymorphism and expression in pre-eclampsia. Clin Exp Immunol. 1996, 104: 154-159. 10.1046/j.1365-2249.1996.d01-647.x.CrossRefPubMedPubMedCentral
21.
go back to reference Stanczuk GA, Sibanda EN, Tswana SA, Bergstrom S: Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer. 2003, 13: 148-53. 10.1046/j.1525-1438.2003.13046.x.CrossRefPubMed Stanczuk GA, Sibanda EN, Tswana SA, Bergstrom S: Polymorphism at the -308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer. 2003, 13: 148-53. 10.1046/j.1525-1438.2003.13046.x.CrossRefPubMed
22.
go back to reference Ghaderi M, Nikitina L, Peacock CS, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Blackwell JM, Dillner J, Sanjeevi CB: Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. Epidemiol Biomarkers Prev. 2001, 9: 1067-1070. Ghaderi M, Nikitina L, Peacock CS, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Blackwell JM, Dillner J, Sanjeevi CB: Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. Epidemiol Biomarkers Prev. 2001, 9: 1067-1070.
23.
go back to reference Hoffman M, Cooper D, Carrara HRO, Rosenberg L, Kelly J, Stander I, Williamson A-L, De toit G, Shapiro S: Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol. 2003, 32: 573-577. 10.1093/ije/dyg081.CrossRefPubMed Hoffman M, Cooper D, Carrara HRO, Rosenberg L, Kelly J, Stander I, Williamson A-L, De toit G, Shapiro S: Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol. 2003, 32: 573-577. 10.1093/ije/dyg081.CrossRefPubMed
24.
go back to reference Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV: ARMS-PCR methodologies to determine IL-10, TNK-alpha and TGF-beta-1 gene polymorphism. Transplant Immunol. 1999, 7: 127-128. 10.1016/S0966-3274(99)80030-6.CrossRef Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV: ARMS-PCR methodologies to determine IL-10, TNK-alpha and TGF-beta-1 gene polymorphism. Transplant Immunol. 1999, 7: 127-128. 10.1016/S0966-3274(99)80030-6.CrossRef
25.
go back to reference Lu W, Pan K, Zhang L, Lin D, Miao X, You W: Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005, 26 (3): 631-6. 10.1093/carcin/bgh349.CrossRefPubMed Lu W, Pan K, Zhang L, Lin D, Miao X, You W: Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005, 26 (3): 631-6. 10.1093/carcin/bgh349.CrossRefPubMed
26.
go back to reference Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M, Cotugno R, Cattaneo F, Zagari MR, Ricciardiello L, Gennarelli M, Bazzoli F, Ranzani GN, Andriulli A: Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine. 2005, 30 (5): 293-302. 10.1016/j.cyto.2005.01.011.CrossRefPubMed Perri F, Piepoli A, Bonvicini C, Gentile A, Quitadamo M, Di Candia M, Cotugno R, Cattaneo F, Zagari MR, Ricciardiello L, Gennarelli M, Bazzoli F, Ranzani GN, Andriulli A: Cytokine gene polymorphisms in gastric cancer patients from two Italian areas at high and low cancer prevalence. Cytokine. 2005, 30 (5): 293-302. 10.1016/j.cyto.2005.01.011.CrossRefPubMed
27.
go back to reference Ferlay J, Bray F, Pisani P: GLOBOCAN 2002: cancer incidence, motality and prevalence worldwide. IARC Press. 2004 Ferlay J, Bray F, Pisani P: GLOBOCAN 2002: cancer incidence, motality and prevalence worldwide. IARC Press. 2004
28.
29.
go back to reference Brinkman JA, Caffrey AS, Muderspach I, Roman LD, Kast WM: The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical cancer lesions: Consequences for clinical management. Eur J Oncol. 2005, 26: 129-142. Brinkman JA, Caffrey AS, Muderspach I, Roman LD, Kast WM: The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical cancer lesions: Consequences for clinical management. Eur J Oncol. 2005, 26: 129-142.
30.
go back to reference Govan VA: Strategies for Human Papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes. Annals NYA Sci. 2005 in press Govan VA: Strategies for Human Papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes. Annals NYA Sci. 2005 in press
31.
go back to reference Wacholder S: Chapter 18: Statistical Issues in the design and analysis of studies of human papillomavirus and cervical neoplasia. J Natl Cancer Inst Monogr. 2003, 31: 125-30.CrossRefPubMed Wacholder S: Chapter 18: Statistical Issues in the design and analysis of studies of human papillomavirus and cervical neoplasia. J Natl Cancer Inst Monogr. 2003, 31: 125-30.CrossRefPubMed
32.
go back to reference Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, Sasagawa T: Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol. 2004, 35 (11): 1376-84. 10.1016/j.humpath.2004.08.012.CrossRefPubMed Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, Sasagawa T: Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol. 2004, 35 (11): 1376-84. 10.1016/j.humpath.2004.08.012.CrossRefPubMed
33.
go back to reference Galloway DA: Papillomavirus vaccines in clinical trials. Lancet Infect Dis. 2003, 8: 469-75. 10.1016/S1473-3099(03)00720-5.CrossRef Galloway DA: Papillomavirus vaccines in clinical trials. Lancet Infect Dis. 2003, 8: 469-75. 10.1016/S1473-3099(03)00720-5.CrossRef
34.
go back to reference Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL, McGovern RM, Sloan JA, Cha SS, Persing DH: TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol. 2003, 3: 326-32. 10.1016/S0090-8258(02)00074-4.CrossRef Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL, McGovern RM, Sloan JA, Cha SS, Persing DH: TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol. 2003, 3: 326-32. 10.1016/S0090-8258(02)00074-4.CrossRef
35.
go back to reference Shelton D, Paturzo D, Flannery J, Gregorio D: Race, stage of disease, and survival with cervical cancer. Ethn Dis. 1992, 2: 47-54.PubMed Shelton D, Paturzo D, Flannery J, Gregorio D: Race, stage of disease, and survival with cervical cancer. Ethn Dis. 1992, 2: 47-54.PubMed
36.
go back to reference Chen F, Trapido EJ, Davis K: Differences in stage at presentation of breast and gynecological cancers among whites, blacks, and Hispanics. Cancer. 1994, 73: 2838-2842.CrossRefPubMed Chen F, Trapido EJ, Davis K: Differences in stage at presentation of breast and gynecological cancers among whites, blacks, and Hispanics. Cancer. 1994, 73: 2838-2842.CrossRefPubMed
Metadata
Title
The allelic distribution of -308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women
Authors
Vandana A Govan
Debbie Constant
Margaret Hoffman
Anna-Lise Williamson
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-6-24

Other articles of this Issue 1/2006

BMC Cancer 1/2006 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine